Navigation Links
Gary Tschautscher of Nonin Medical, Inc. Receives CEO of 2007 for North American Patient Monitoring From Frost & Sullivan
Date:1/9/2008

MINNEAPOLIS, Jan. 9 /PRNewswire/ -- Nonin Medical, Inc.'s CEO, Gary Tschautscher received the highly regarded Industry Best Practices Award for CEO of 2007 for the North American Patient Monitoring Industry from Frost & Sullivan. Frost & Sullivan recognizes outstanding industry achievements in regional and global markets and the Awards are recognized worldwide by the media, the investment community and end-user markets. The global growth consulting company honored Tschautscher for his pioneering vision and strategic affiliations to bring Nonin's robust, portable and easy-to-use pulse oximetry technology to more people and applications worldwide.

"As a result of its strategic efforts in ongoing product innovation and support activities, Nonin has doubled its market share and achieved worldwide coverage, penetrating alternate care markets as well as leading the sleep diagnostic market," reported Frost and Sullivan. With well over 1 million oximeters sold worldwide, Nonin's oximeters have opened up a whole new direction in patient care in both acute care and alternate care markets. A number of Nonin's innovative "firsts" include the world's first self-contained fingertip oximeter, the first low power handheld oximeter and the first Bluetooth(R) Wireless Oximeter. Because of their accuracy, small size and portability,

Tschautscher and his management team have approached physiological monitoring with vigor, providing the most extensive line of pulse oximetry, capnography, software and sensors to both the human and veterinary markets. Tschautscher's boundless enthusiasm begins with his true care for the patient. "We are making a difference in how patients are cared for and that makes it all worthwhile. Our ultimate goal is to simplify patient monitoring and keep our focus on the future and how patient care is evolving."

About Nonin Medical, Inc. - http://www.nonin.com

Minneapolis-based Non
'/>"/>

SOURCE Nonin Medical, Inc.
Copyright©2008 PR Newswire.
All rights reserved

0

GOOD

Page: 1 2

Related medicine news :

1. Noninvasive tests for cirrhosis may help to avoid liver biopsy
2. Breaking Study: Masimo Pleth Variability Index (PVI) Shown Effective in Noninvasive Detection of Changes in Ventricular Preload and Fluid Volume
3. Nonin Medical is Honored With Niche Supplier Award from Amerinet
4. Medical, technological advances prompt updating of nuclear medicine technologists scope of practice
5. Cardiva Medical, Inc. to Present at the UBS 2007 Global Life Science Conference With the Announcement of FDA 510(K) Clearance of its Newest Device: The Boomerang Catalyst II System(TM)
6. Cardiva Medical, Inc. to Present at the UBS 2007 Global Life Science Conference With the Announcement of FDA 510(K) Clearance of its Newest Device: The Boomerang Catalyst II System(TM)
7. Thermage, Inc. Announces Distribution Agreement With Eclipse Medical, Ltd.
8. Medical, Behavioral Woes Can Drive Dogs to Bite
9. ReBuilder Medical Technologies, Inc. Announces UK Demand for Safe Molluscum Contagiosum Treatment Leads to Distribution Agreement with UFFE Medical, LTD. Expected 10% Sales Increase.
10. Sedgwick CMS and UnitedHealth Group to Develop Integrated Disability, Medical, Workers Compensation and Leave Administration Services for Employers
11. Emmaus Medical, Inc. Enters Into Sub-License Agreement for Treatment of Short Bowel Syndrome

Post Your Comments:
*Name:
*Comment:
*Email:
(Date:11/25/2009)...swire/-SentinelleMedicalInc.,aleadingmanufacturero...nchesasuiteofnewleadingedgeclinicalapplicationsoni...r,sRadiologicalSocietyofNorthAmerica(RSNA)annualme...Theapplicationsleveragetheuniquehighqualityimagesg...dsupportmultipleimagingmodalitiesformulti-parametr...
(Date:11/25/2009)....25/PRNewswire-USNewswire/--AnarticlebyJanetWoodco...ndResearch,titled"ADifficultBalance-PainManagement...eofTheNewEnglandJournalofMedicine. ,, (Logo: ht... ) ,, Inthearticle,WoodcockdiscussesFDAeffortst...sewhoneeditandmanagingtherisksposedbyvariousanalge...
(Date:11/25/2009)...PRNewswire/--TheBayAreaAirQualityManagementDistric... Air Alert forThursday,November26,2009which...dfuel,bothindoorsandoutdoors. ,, "Cold,stillwea...aidJackBroadbent,executiveofficeroftheAirDistrict....eirneighborsandfellowcommunitymembersthisThanksgiv...
(Date:11/25/2009)...ticular cancer who were treated with cisplatin-bas...uding neurological side effects and Raynaud-like p...therapy, according to a new study published online...r Institute . , Marianne Brydy, M.D., of the Dep..., in Bergen, Norway, and colleagues conducted a cr...
(Date:11/25/2009)...hat grew out of a collaboration between UCLA engin...o the nearly 10 million Americans who suffer from ... hardening of the arteries, peripheral arterial di...which narrowed arteries reduce blood flow to the l...ascular disease, heart attack and stroke, and its ...
Breaking Medicine News(10 mins):Health News:Sentinelle Medical Launches Aegis Suite of Oncology 4D Visualization Software with PureWeb(TM) Technology 2Health News:Sentinelle Medical Launches Aegis Suite of Oncology 4D Visualization Software with PureWeb(TM) Technology 3Health News:Winter Spare the Air Alert in Effect for Thursday, November 26, 2009 2Health News:Engineers, doctors at UCLA develop novel material that could help fight arterial disease 2Health News:Engineers, doctors at UCLA develop novel material that could help fight arterial disease 3Health News:Engineers, doctors at UCLA develop novel material that could help fight arterial disease 4
...Dutch Vaccine Guarantor Selects Sparta Systems, So...Across the Organization , , HOLMDEL, N.J., March ...erprise quality and compliance management software... the Dutch population, has selected the TrackWise ...
... An unlikely brew of seaweed and glow-in-the-dark ...e of transplanted stem cells to treat patients wit...ing to a team of veterinarians, basic scientists a...ully delivered therapeutic stem cells via intramus...
... Arnhem, 10 March 2009 -- The standard Prostate Sp...ot tell the difference between aggressive and slow...will be held from 17 to 21 March 2009 in Stockholm... aggressive and non-aggressive prostate cancers: s...
...Ankle Brachial Index (ABI) Identifies Peripheral A...sk Who Were Missed by Framingham Risk Score in 6,2...ch 10 The use of common and readily available scr...o prevent devastating heart attacks in thousands o...
...Interventional Radiologists Help Peripheral Arteri...mia Avoid Amputation , , SAN DIEGO, March 10 At...al arterial disease (PAD) patients with below-the-...nts and the continued progression of atherosclerot...
...Certification Underscores Lionbridge,s Market-Lead...es Organizations Worldwide , , WALTHAM, Mass., Ma...ed that it recently received ISO 13485:2003 certif...m and enhances the Company,s translation managemen...
Other Medicine News:Health News:Netherlands Vaccine Institute Chooses TrackWise(R) Solution for Enterprise-wide Compliance with Good Manufacturing Practices 2Health News:Netherlands Vaccine Institute Chooses TrackWise(R) Solution for Enterprise-wide Compliance with Good Manufacturing Practices 3Health News:Netherlands Vaccine Institute Chooses TrackWise(R) Solution for Enterprise-wide Compliance with Good Manufacturing Practices 4Health News:Seaweed and fireflies brew may guide stem cell treatment for peripheral artery disease 2Health News:Dr. Arun Sreekumar lectures on new candidate biomarker at Annual EAU Congress 2Health News:Simple Test Helps Predict Heart Attack Risk 2Health News:Simple Test Helps Predict Heart Attack Risk 3Health News:Simple Test Helps Predict Heart Attack Risk 4Health News:Promising Three-year Data: Saving Limbs With Drug-Eluting Stents 2Health News:Promising Three-year Data: Saving Limbs With Drug-Eluting Stents 3Health News:Promising Three-year Data: Saving Limbs With Drug-Eluting Stents 4Health News:Lionbridge Receives ISO 13485:2003 Certification for Quality Management 2
(Date:11/25/2009)..., PHILADELPHIA,Nov.25/PRNewswire-FirstCall/--ERT(N...ey,theCompany,sPresidentandCEO,andKeithSchneck,the...topresentatthe21stAnnualPiperJaffrayHealthCareConf...York. ,, Interestedpartiesmayaccessthepresentat.../www.ert.com .Thewebcastmayalsobeaccessedat http:/...
(Date:11/25/2009)..., EXTON,Pa.,Nov.25/PRNewswire/--BioTrendsResearchG...Stelara report,thefirstinamulti-phasesyndicatedma...o-Biotech,sStelara,fromproductlaunchthroughthefirs...esquantitativeinformationfrom75uniqueDermatologist...tsassesstrialanduseofStelara,obstaclestouse,typica...
(Date:11/25/2009)..., WESTPALMBEACH,Fla.,Nov.25/PRNewswire-FirstCall/-...peciallythe27millionlivingwithuntreated hearinglos...CindyBeyer. ,, Dr.Beyer,seniorvicepresidentofHe...and hearingaids companies,saidstudieshavelinkedhea...hichcaneasilybeintensifiedatholidaygatheringswithf...
Breaking Medicine Technology:ERT to Present at the 21st Annual Piper Jaffray Health Care Conference on December 1, 2009 2Despite Managed Care Obstacles, Interest and Anticipated Use of Centocor Ortho-Biotech's New Psoriasis Agent Stelara (ustekinumab) is High 2For Millions With Untreated Hearing Loss, Holiday Season Can be Especially Difficult 2iPierian Appoints Dr Matthew J Plunkett as Chief Financial Officer 13765 1iPierian Appoints Dr Matthew J Plunkett as Chief Financial Officer 13765 2Chemotherapy Linked to Sleep Wake Cycle Disruptions 55838 1Chemotherapy Linked to Sleep Wake Cycle Disruptions 55838 2National Changing Diabetes Program Supports Improvements in Health Cost Estimates 55833 1National Changing Diabetes Program Supports Improvements in Health Cost Estimates 55833 2National Changing Diabetes Program Supports Improvements in Health Cost Estimates 55833 3National Changing Diabetes Program Supports Improvements in Health Cost Estimates 55833 4National Changing Diabetes Program Supports Improvements in Health Cost Estimates 55833 5
..., 2007 /PRNewswire-FirstCall/ - Helix today,announ...udy of its,Topical Interferon Alpha-2b in women wi...ervical lesions. , The study showed a clinically e... the treated patients. In addition, the product,de...gnificant local,intolerance or drug-related seriou...
...ith Diabetes, Hospital,and Professional Charges Lo..., April 02, 2007 /PRNewswire-FirstCall/ -- The,Pit...today the,release of a new report on the prevalenc...2 diabetes. The inaugural Pittsburgh Type,2 Diabet...,demographics, hospital and professional charges, ...
Other Medicine Technology:Helix BioPharma Corp. Announces Positive Phase II Clinical Results,with its Topical Interferon Alpha-2b 2Helix BioPharma Corp. Announces Positive Phase II Clinical Results,with its Topical Interferon Alpha-2b 3Helix BioPharma Corp. Announces Positive Phase II Clinical Results,with its Topical Interferon Alpha-2b 4Helix BioPharma Corp. Announces Positive Phase II Clinical Results,with its Topical Interferon Alpha-2b 5Helix BioPharma Corp. Announces Positive Phase II Clinical Results,with its Topical Interferon Alpha-2b 6State of Diabetes in Pittsburgh: Pittsburgh Business Group on,Health Releases Report 2State of Diabetes in Pittsburgh: Pittsburgh Business Group on,Health Releases Report 3State of Diabetes in Pittsburgh: Pittsburgh Business Group on,Health Releases Report 4
...areCollect™ improves the specimen collection ... patient information on the handheld at the bedsid...pecific patient. Collection status information can...educe redraws, enhancing patient comfort, and maki...
...rizon Admin-Rx is a bar-code medication administra...the medication administration process with bar-cod...canner in a handheld or laptop device to verify th... at the right time in the right dosage via the rig...
wCareMed™
...diMAR™ is the newest Mediware product, which ...record. MediMAR produces a dynamic and complete re...including clinician orders, medication list, aller...ion or alerts that increase patient safety. MediMA...
Medicine Products: